Or if you're already a Cold Chain IQ member, sign in below to download. Sign In Subscribe
In this interview Johannes Schoen, Senior Manager, Anti-Counterfeiting at Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about the key uncertainties surrounding pharmaceutical serialisation and the impact recent serialisation initiatives will have on the pharma industry. Schoen also shares his thoughts on the implications the EU directive on falsified medicines will have the generics market and his top tips for improving supply chain visibility.
|Have Your Say|
Rate this feature and give us your feedback in the comments section below